Stay updated on Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site footer's software revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check22 days agoChange DetectedA notice announces NIH website updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.3%

- Check28 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check35 days agoChange DetectedThe website footer now displays software revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page history now shows a new site revision (v3.7.0) replacing the previous v3.6.6, indicating a technical update to the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check77 days agoChange DetectedThe revision tag in the study record history was updated to v3.6.6, signaling a newer version of the page. It is a metadata update and does not alter the trial data or displayed content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.